Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

L. Erdem-Eraslan; L.A. Gravendeel; J. de Rooi; P.H.C. Eilers; A. Idbaih; W.G.M. Spliet; W.F.A. den Dunnen; J.L. Teepen; P. Wesseling; P.A.E.S. Smitt; J.M. Kros; T Gorlia; M.J. van den Bent; P.J. French

doi:https://doi.org/10.1200/JCO.2012.44.1444

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

L. Erdem-Eraslan, L.A. Gravendeel, J. de Rooi, P.H.C. Eilers, A. Idbaih, W.G.M. Spliet, W.F.A. den Dunnen, J.L. Teepen, P. Wesseling, P.A.E.S. Smitt, J.M. Kros, T Gorlia, M.J. van den Bent, P.J. French

Pathology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

88 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	328-336
Journal	Journal of clinical oncology
Volume	31
Issue number	3
DOIs	https://doi.org/10.1200/JCO.2012.44.1444
Publication status	Published - 2013

Access to Document

https://doi.org/10.1200/JCO.2012.44.1444

Cite this

Erdem-Eraslan, L., Gravendeel, L. A., de Rooi, J., Eilers, P. H. C., Idbaih, A., Spliet, W. G. M., den Dunnen, W. F. A., Teepen, J. L., Wesseling, P., Smitt, P. A. E. S., Kros, J. M., Gorlia, T., van den Bent, M. J., & French, P. J. (2013). Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. Journal of clinical oncology, 31(3), 328-336. https://doi.org/10.1200/JCO.2012.44.1444

Erdem-Eraslan, L. ; Gravendeel, L.A. ; de Rooi, J. et al. / Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. In: Journal of clinical oncology. 2013 ; Vol. 31, No. 3. pp. 328-336.

@article{d3ac72c152e44360bf2a2809c341935c,

title = "Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951",

author = "L. Erdem-Eraslan and L.A. Gravendeel and {de Rooi}, J. and P.H.C. Eilers and A. Idbaih and W.G.M. Spliet and {den Dunnen}, W.F.A. and J.L. Teepen and P. Wesseling and P.A.E.S. Smitt and J.M. Kros and T Gorlia and {van den Bent}, M.J. and P.J. French",

year = "2013",

doi = "https://doi.org/10.1200/JCO.2012.44.1444",

language = "Undefined/Unknown",

volume = "31",

pages = "328--336",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "3",

}

Erdem-Eraslan, L, Gravendeel, LA, de Rooi, J, Eilers, PHC, Idbaih, A, Spliet, WGM, den Dunnen, WFA, Teepen, JL, Wesseling, P, Smitt, PAES, Kros, JM, Gorlia, T, van den Bent, MJ & French, PJ 2013, 'Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951', Journal of clinical oncology, vol. 31, no. 3, pp. 328-336. https://doi.org/10.1200/JCO.2012.44.1444

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. / Erdem-Eraslan, L.; Gravendeel, L.A.; de Rooi, J. et al.
In: Journal of clinical oncology, Vol. 31, No. 3, 2013, p. 328-336.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951

AU - Erdem-Eraslan, L.

AU - Gravendeel, L.A.

AU - de Rooi, J.

AU - Eilers, P.H.C.

AU - Idbaih, A.

AU - Spliet, W.G.M.

AU - den Dunnen, W.F.A.

AU - Teepen, J.L.

AU - Wesseling, P.

AU - Smitt, P.A.E.S.

AU - Kros, J.M.

AU - Gorlia, T

AU - van den Bent, M.J.

AU - French, P.J.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1200/JCO.2012.44.1444

DO - https://doi.org/10.1200/JCO.2012.44.1444

M3 - Article

C2 - 23269986

SN - 0732-183X

VL - 31

SP - 328

EP - 336

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 3

ER -

Erdem-Eraslan L, Gravendeel LA, de Rooi J, Eilers PHC, Idbaih A, Spliet WGM et al. Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951. Journal of clinical oncology. 2013;31(3):328-336. doi: https://doi.org/10.1200/JCO.2012.44.1444